Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 75,700
+800 (1.07%)
At close: Feb 26, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 623.5 billion as of February 27, 2026. Its market cap has increased by 64.75% in one year.
Market Cap
623.50B
Enterprise Value
604.32B
Revenue
14.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
75,700.00
Market Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 623.50B, an increase of 228.52%. That is a compound annual growth rate of 118.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 623.50B | -14.99% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 492.92B |
| MEDIANA Co.,Ltd | 380.09B |
| L&K Biomed | 259.27B |
| SELVAS Healthcare | 129.62B |
| Remed | 105.08B |
| Noul Co.,Ltd. | 93.15B |
| QuantaMatrix | 80.54B |
| Hironic | 74.74B |